Guest Editors who wish to submit an issue proposal to Current Pharmaceutical Biotechnology are requested to complete the following online form. The proposal of thematic issue will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of Current Pharmaceutical Biotechnology who will then inform Guest Editors with a decision about the submitted proposal.
Davide Prosperi Department of Biotechnology and Bioscience University of Milano-Bicocca Milano Italy
Prof. Davide Prosperi is Associate Professor in Biochemistry at the University of Milano Bicocca (Unimib), Department of Biotechnology and Bioscience. Head of the NanoBioLab of Unimib, he is devoted to biomedical and biophysical applications of nanotechnology. In particular, the research activity of Davide Prosperi involves the design, synthesis, functionalization and characterization of colloidal, polymeric and biomimetic nanoparticles for biomedical applications, with particular focus on the diagnosis and treatment of cancer and inflammatory diseases. He is author of over 100 scientific publications. He is one of the author of the patent “Nanoconstructs with pharmacological activity” (n° WO2014013473-A1), and co-founder of the spin-off company inTHEna srl, aiming to design and development of molecules, nanostructures and technologies for biomedical studies and diagnosis, prevention and therapy of human and animal diseases.